SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant volatility as investors react to a planned 40 billion dollar equity and debt raise, which overshadowed the company's strong revenue beat and record cloud backlog. Community discussions are split between those viewing the spending as a necessary, high-growth investment in AI infrastructure and others fearing shareholder dilution and excessive debt in an already sensitive tech market.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing extreme volatility as investors react to a significant capital raise, sparking intense debate over whether the move is a necessary step to support massive AI order backlogs or a dilutive blow to current shareholders. The community is deeply polarized, with bulls viewing the pullback as a buying opportunity in a high-demand sector while bears emphasize concerns regarding management's transparency and potential for further dilution.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as market participants react to escalating geopolitical tensions in Iran, a hotter-than-expected inflation print, and investor concern regarding upcoming liquidity outflows for the SpaceX IPO. Community discourse is polarized, with bears capitalizing on the breakdown of tech support levels while bulls remain focused on potential peace deal headlines and volatile overnight trading activity.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant volatility as market participants rotate capital ahead of the upcoming SpaceX IPO, with investors debating whether the stock is a primary funding vehicle for the launch or an overextended asset facing distraction risks. Community discussion is heavily divided between bullish sentiment fueled by recent FSD regulatory approvals and a high price target from Piper Sandler, and bearish concerns surrounding the stock's valuation, competition, and the potential impact of corporate leadership overlap.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users closely monitor the escalating conflict with Iran and the resulting impact on inflation and market stability. The community is actively debating the geopolitical consequences of recent strikes, the potential for economic volatility, and the validity of official announcements regarding diplomatic progress.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

The SPDR Gold Shares ETF (GLD) is experiencing heightened volatility and selling pressure as investors rotate away from precious metals, driven by sticky inflation data and shifting interest rate expectations. The community remains deeply divided, with many debating whether this breakdown is a buying opportunity or a structural shift indicating a loss of gold's traditional safe-haven status.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense trading volume and volatility as the stock captures institutional interest amid broader semiconductor sector shifts. The community is actively debating the company's long-term sustainability as a storage leader versus cyclical memory stock, with many traders closely watching support levels following a rapid series of price swings.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing significant volatility as investors weigh the R2 launch against broader market headwinds and concerns over the company's path to profitability. The community remains deeply divided, with bulls pointing to positive product reviews and long-term production potential, while skeptics emphasize persistent cash burn and the challenges of competing in an increasingly crowded EV market.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF (GDX) is facing extreme volatility amid the ongoing conflict in Iran, with the community actively debating whether current price action represents a technical breakdown or a generational buying opportunity. Investors are closely monitoring rising energy costs and potential Fed rate adjustments, while many remain committed to long-term positions based on the belief that central bank demand and structural metal deficits will drive future appreciation.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

Investors are actively debating the viability of holding the leveraged SMCX ETF following a recent reverse split and significant volatility in the underlying SMCI stock. Many community members are warning of severe decay in leveraged products while others attempt to time aggressive entries, citing concerns over management issues and the inherent risks of holding double-leveraged instruments long-term.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing Bioventus (BVS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Medical Stocks Lagging  Allarity Therapeutics, Inc. (ALLR) This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Bioventus (BVS) have performed compared to their sector so far this year.

After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)

The heavy selling pressure might have exhausted for Bioventus (BVS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts

The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire TAMPA, Fla., June 2, 2026 Issued on behalf of Conexeu Sciences Inc.A newly listed...

Transcript: Bioventus Q1 2026 Earnings Conference Call

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Bioventus (BVS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Is Bioventus (BVS) Stock Undervalued Right Now?

Are Medical Stocks Lagging  Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?

The consensus price target hints at a 39% upside potential for Bioventus (BVS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

BVSBioventus Inc - Ordinary Shares - Class A

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BVS News